Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By

26:45
June 21, 2025 - PBS News Weekend full episode

56:44
June 20, 2025 - PBS News Hour full episode

57:46
June 19, 2025 - PBS News Hour full episode

57:46
June 18, 2025 - PBS News Hour full episode

57:46
June 17, 2025 - PBS News Hour full episode

57:46
June 16, 2025 - PBS News Hour full episode

26:45
June 15, 2025 - PBS News Weekend full episode

26:45
June 14, 2025 - PBS News Weekend full episode

57:46
June 13, 2025 - PBS News Hour full episode

57:46
June 12, 2025 - PBS News Hour full episode

57:46
June 11, 2025 - PBS News Hour full episode

57:46
June 10, 2025 - PBS News Hour full episode